(Q37702726)

22 August 2017

1 reference

title

Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review (English)

1 reference

American Heart Association

22 August 2017

author

4

object named as

American Heart Association

1 reference

American Stroke Association

22 August 2017

5

object named as

American Stroke Association

1 reference

22 August 2017

B Brent Simmons

1

1 reference

22 August 2017

Albert Yeo

2

1 reference

22 August 2017

Kent Fung

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

22 August 2017

published in

Postgraduate Medicine

1 reference

22 August 2017

volume

122

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

49-53

1 reference

Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

The mechanism of action of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

A metaregression analysis of the dose-response effect of aspirin on stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counci

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2121

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.03.2121

1 reference

release_uxx5nzn5tngeffnbyb5qhi2rbi

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uxx5nzn5tngeffnbyb5qhi2rbi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference